Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts. - Wikidata - wikimedia - TriplyDB

Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts.

Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts.

http://www.wikidata.org/entity/Q35053098

about

A novel semi-supervised methodology for extracting tumor type-specific MRS sources in human brain data Convex non-negative matrix factorization for brain tumor delimitation from MRSI data.Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.Integrating Tenascin-C protein expression and 1q25 copy number status in pediatric intracranial ependymoma prognostication: A new model for risk stratification.Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial.Non-negative matrix factorisation methods for the spectral decomposition of MRS data from human brain tumours Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.Systematic comparison of MRI findings in pediatric ependymoblastoma with ependymoma and CNS primitive neuroectodermal tumor not otherwise specified.Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.Biology and management of ependymomas.Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities Treatment implications of posterior fossa ependymoma subgroups.The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.Vascular patterns of brain tumors.Spinal cord ependymomas in children and adolescents.Current and evolving knowledge of prognostic factors for pediatric ependymomas.Prognostic marker analysis in pediatric intracranial ependymomas.Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma.Posterior fossa ependymoma: current insights.Advances in Management of Pediatric Ependymomas.Pediatric Ependymoma.Understanding Ependymoma Oncogenesis: an Update on Recent Molecular Advances and Current Perspectives.Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.The new WHO 2016 classification of brain tumors-what neurosurgeons need to know.Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas.Evaluation of chromosome 1q gain in intracranial ependymomas.Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.Toward an integrated histomolecular diagnosis of supratentorial ependymoma.Molecular dissection of ependymomas.Nestin expression identifies ependymoma patients with poor outcome.Apparent diffusion coefficient of pediatric cerebellar tumors: a biomarker of tumor grade?Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression.

P2860

Q30000658-68FCC845-ED54-4858-9C0D-DC70775A4D57 Q30575323-204724D6-F00E-484D-9731-C1B04686CC94 Q30613404-B53AF799-1958-4E93-9F19-09F262138A36 Q33803137-CCE40819-3154-4E3B-BD57-EB5A01AE60B9 Q33993483-51FA4337-D99E-428E-856C-41CDDD5C1D22 Q34188634-C2CF1850-5D22-4532-9AD8-AC253A7E1D68 Q35754390-EC35C731-018E-4D9C-81B4-90AAF29F39FA Q35815310-872F530C-E094-4EFD-B9E0-1690F1FDF81B Q36070798-80C4D46C-FFB0-43E8-A7C4-AA14C02796D6 Q36461766-2E7936D4-49EE-4474-99F2-F1BB07DC375B Q36560149-D34118A8-EC90-4BD6-B06E-95F14CF411E7 Q36977704-28DF0920-5891-43AF-93FC-8F3E2919FB15 Q36977707-6B8FA367-2B19-47ED-97BA-E069D277B30B Q37130238-CA98BFD3-C4C6-4A3C-AFF5-E846BAF080B7 Q37196135-2FB116B7-1C1B-462A-B481-D81C685267DD Q37213305-71E83A1A-938C-4CD8-9D17-094FA437832A Q37416967-405B73A2-0844-41C2-A820-F929E4C1FE30 Q37553466-449D8499-EF4B-44B7-8C23-7AB2A95A2E44 Q37641698-03134D1F-178F-42C5-A026-1D60DAC82A2A Q37727557-D9C6D0F9-A015-4C53-BEEC-9F26F9970E7F Q37921513-9F86B777-73EB-4452-8118-D25482958958 Q38041984-73104461-A7F2-458F-AB0F-92D9448B9A5C Q38081982-1ED5ADF9-8E4A-4FA1-8ECF-AFD39D90152D Q38309196-C1CA6D42-66E6-4BD0-8B95-6A06CEC579E9 Q38399886-F265B5B6-96AB-49FC-BD39-9C63FA6A431E Q38583252-C26C212C-D7A1-469C-AFA3-51299BB9E308 Q38586580-50FE51BF-7478-44A0-8BB2-7E7042D5D795 Q38616800-52569AFE-E20A-401F-A2B6-FA463FD7DB93 Q38681915-40F51FEC-CAFB-4744-9779-9593B10A4D50 Q38858546-6AE89ACA-6D9B-40AB-859F-CEEF9C473FE9 Q38865516-B1820E59-B917-4A74-A3AE-309E04B8C7C6 Q39091307-8F6B07FB-B538-4282-ADBD-047D96670313 Q39316156-2FA5AD87-B926-415C-AB49-3B4F646C7D48 Q40150706-E4B81A2D-4607-44F8-B25F-2D73456E16CC Q40190070-B721A834-9E79-4D31-B281-63CA9FBCDF59 Q42738552-9ABD63BA-2B83-4D84-B4BF-EE71B0E4BF90 Q43141039-46A60CC1-E4D2-408B-BB46-E2BA99CCF3D0 Q43662312-2A69E7DD-C474-4654-8619-03EAC0AF3936 Q44251430-A1676C01-FCD0-4F27-A39A-F47613A14E05 Q44856848-5E967D00-5CD8-44EB-876D-8A158479FFA6

P2860

Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts.

http://www.wikidata.org/entity/Q35053098

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Histopathological grading of p ...... nce in European trial cohorts.

@ast

Histopathological grading of p ...... nce in European trial cohorts.

@en

type

label

Histopathological grading of p ...... nce in European trial cohorts.

@ast

Histopathological grading of p ...... nce in European trial cohorts.

@en

prefLabel

Histopathological grading of p ...... nce in European trial cohorts.

@ast

Histopathological grading of p ...... nce in European trial cohorts.

@en

P1433

Q35053098-075DE63D-4B61-416F-89FB-923E652FDAB7

P1476

Q35053098-4782C2F0-013F-4DF7-8946-D7178CB7FEEB

P2093

Q35053098-19B9091A-AF05-4381-B510-9AD559F31D2C

Q35053098-291B554B-191C-4BE3-9C36-C8025FEC6FA3

Q35053098-3BDB9A0B-E880-4B49-8B4C-C7C016454D26

Q35053098-4C92D00F-8DF0-4DE8-B45C-CCEBFA5BFA19

Q35053098-767F49F0-571C-47A5-B65F-E0B2E648F449

Q35053098-B19C986C-B564-4690-90A2-DF043B367F28

Q35053098-F5B28C4F-9485-4452-8619-05F8A01AB068

P2860

Q35053098-0976E332-BDBE-4732-AFC2-0CF2904064DC

Q35053098-19E3E293-2966-4DDF-A6F7-DCF9BFCB136C

Q35053098-1D4E6BEC-0EF5-4F1C-B392-7702E974E264

Q35053098-235537EE-FD56-4114-9C2A-C0DCA6BDB2E7

Q35053098-2F8608EC-0FB7-43B8-9D8F-A0EA535C420A

Q35053098-329DC14B-6159-476C-9CEF-1793362F8517

Q35053098-44830D7D-B0A5-4175-A614-F1B093731FC4

Q35053098-51AB01C7-6540-4E73-8D6A-D4983C16716E

Q35053098-62ABDBFC-4B21-4D01-B7B0-AED78DAAF391

Q35053098-63F0D0B1-0222-48F6-B5D5-4E99B9A93235

P304

Q35053098-7D4A906D-F636-4B40-B525-8B6EB58BD2D8

P31

Q35053098-FD52B800-C7AE-4695-984F-F07333CE5C5E

P356

Q35053098-DB023C91-77AE-4DE0-8DD2-489B9106EC23

P478

Q35053098-0CF33BFC-3234-4FCC-941B-129906942761

P50

Q35053098-0DB2E79F-335F-415E-93E1-52D9ACE707F9

Q35053098-2A7AC56D-B628-4618-93F5-5C7C4D8FB8CF

Q35053098-CBB7A5A8-C1BE-448B-912B-845FFBB151CA

Q35053098-EFD6CB7A-D5E2-49A2-96A3-07BDA54EE59F

P577

Q35053098-C181C2FE-CCA1-4ECC-8521-868872446355

P5875

Q35053098-CCAC34E3-913C-4058-A950-22828A3B570F

P698

Q35053098-FB7C8BD6-4C7B-4769-A9B4-F3CBB0EB4E89

P921

Q35053098-2F834A81-2F8C-4D39-9870-9D24F90D5F9D

P932

Q35053098-F9919384-84F0-4A96-91AB-441ACCF140CA

P356

P1433

Journal of Negative Results in BioMedicine

P1476

Histopathological grading of p ...... nce in European trial cohorts.

@en

P2093

David W Ellison

http://www.w3.org/2001/XMLSchema#string

Didier Frappaz

http://www.w3.org/2001/XMLSchema#string

Giangaspero Felice

http://www.w3.org/2001/XMLSchema#string

Godfraind Catherine

http://www.w3.org/2001/XMLSchema#string

James M Boyett

http://www.w3.org/2001/XMLSchema#string

Richard G Grundy

http://www.w3.org/2001/XMLSchema#string

Torsten Pietsch

http://www.w3.org/2001/XMLSchema#string

P2860

Multifactorial analysis of predictors of outcome in pediatric intracranial ependymoma

The 2007 WHO classification of tumours of the central nervous system

Lack of histopathological correlation of malignant ependymomas with postoperative survival.

Ependymoma: new therapeutic approaches including radiation and chemotherapy.

Ki-67 immunolabeling index is an accurate predictor of outcome in patients with intracranial ependymoma.

Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.

ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.

Radial glia cells are candidate stem cells of ependymoma.

Identification of gains on 1q and epidermal growth factor receptor overexpression as independent prognostic markers in intracranial ependymoma.

P304

7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-5751-10-7

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Maura Massimino

Dominique Figarella-Branger

P577

2011-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51179689

http://www.w3.org/2001/XMLSchema#string

P698

21627842

http://www.w3.org/2001/XMLSchema#string

P921

reproducibility

P932

3117833

http://www.w3.org/2001/XMLSchema#string